Lexicon Pharmaceuticals (LXRX) Goodwill & Intangibles (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Goodwill & Intangibles data on file, last reported at $44.5 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles changed 0.0% year-over-year to $44.5 million in Q1 2026; TTM through Mar 2026 was $44.5 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $44.5 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $44.5 million, roughly flat from $44.5 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for LXRX reached as high as $44.5 million in Q1 2022 and fell as low as $44.5 million in Q1 2022.
• Historically, Goodwill & Intangibles has averaged $44.5 million across 5 years, with a median of $44.5 million in 2022.
• On a YoY basis, Goodwill & Intangibles climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Year by year, Goodwill & Intangibles stood at $44.5 million in 2022, then changed by 0.0% to $44.5 million in 2023, then changed by 0.0% to $44.5 million in 2024, then changed by 0.0% to $44.5 million in 2025, then changed by 0.0% to $44.5 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $44.5 million in Q1 2026, $44.5 million in Q4 2025, and $44.5 million in Q3 2025.